Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-31 @ 7:44 PM
Study NCT ID:
NCT02879994
Status:
COMPLETED
Last Update Posted:
2021-07-14
First Post:
2016-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-23
First Submit QC Date:
None
Study First Post Date:
2016-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-11
Results First Submit QC Date:
None
Results First Post Date:
2021-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-24
Last Update Post Date:
2021-07-14
Last Update Post Date Type:
ACTUAL